Study Links Higher BMI to Pregnancy Complications in Type 2 Diabetes
An Australian study reveals that elevated pre-pregnancy BMI significantly increases the risk of pre-eclampsia and preterm delivery in women with Type 2 diabetes.
Higher pre-pregnancy BMI correlates with increased risks of pre-eclampsia and preterm delivery in Type 2 diabetes.
The study analyzed 264 pregnancies, revealing significant differences in outcomes based on BMI categories.
Findings suggest a need for larger studies to confirm the impact of maternal weight on pregnancy outcomes.
A recent study conducted in Australia has highlighted a concerning link between elevated pre-pregnancy body mass index (BMI) and adverse pregnancy outcomes in women diagnosed with Type 2 diabetes. The research, which examined 264 singleton pregnancies managed at a quaternary hospital in Sydney from 2010 to 2019, found that women with higher BMI faced increased risks of pre-eclampsia and preterm delivery.
The study specifically focused on two groups of women: those with Type 1 diabetes (T1DM) and those with Type 2 diabetes (T2DM). It was noted that among women with T2DM, 20.5% of those classified as obese experienced pre-eclampsia, compared to only 2.7% of women with overweight and 7.7% with normal weight. Furthermore, the risk of preterm delivery was significantly higher in the obese category, with rates reaching 42.2% compared to 30.6% for those with overweight.
Researchers utilized a retrospective analysis of data to assess the impact of BMI on pregnancy outcomes, focusing on key metrics such as pre-eclampsia, preterm delivery, and the incidence of infants born large for gestational age (LGA). The findings indicated that every 1 kg/m² increase in BMI above the normal range was associated with an 8.2% increase in the odds of pre-eclampsia and a 4.2% increase in the odds of preterm delivery.
Interestingly, the study found no significant associations between increasing BMI and adverse outcomes in women with T1DM. However, higher BMI was linked to poorer glycaemic control in this group, with a substantial percentage of overweight and obese women exceeding the early glycaemic target. This suggests that while the risks differ between the two types of diabetes, the implications of weight management remain critical for both groups.
The authors of the study emphasized the exploratory nature of their regression analyses and acknowledged the limitations due to the small sample size, particularly among women with obesity in the T1DM group. They called for larger, more comprehensive studies to further investigate how maternal weight influences pregnancy outcomes in women with both types of diabetes, aiming to establish clearer guidelines for managing weight in this vulnerable population.
